Insider Selling: Illumina CEO Sells 30,000 Shares of Stock (ILMN)
Illumina (NASDAQ:ILMN) CEO Jay T. Flatley sold 30,000 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $160.43, for a total value of $4,812,900.00. Following the sale, the chief executive officer now directly owns 385,105 shares of the company’s stock, valued at approximately $61,782,395. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Illumina (NASDAQ:ILMN) traded up 0.34% on Friday, hitting $164.33. 1,393,036 shares of the company’s stock traded hands. Illumina has a 1-year low of $48.00 and a 1-year high of $165.45. The stock has a 50-day moving average of $135.5 and a 200-day moving average of $99.40. The company has a market cap of $20.822 billion and a P/E ratio of 181.97.
Illumina (NASDAQ:ILMN) last released its earnings data on Tuesday, January 28th. The company reported $0.45 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.44 by $0.01. The company had revenue of $387.00 million for the quarter, compared to the consensus estimate of $382.06 million. During the same quarter last year, the company posted $0.42 earnings per share. Illumina’s revenue was up 25.1% compared to the same quarter last year. Analysts expect that Illumina will post $2.06 EPS for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Leerink Swann set a $160.00 price target on shares of Illumina in a research note on Wednesday, January 29th. Separately, analysts at Mizuho raised their price target on shares of Illumina from $150.00 to $175.00 in a research note on Wednesday, January 29th. They now have a “buy” rating on the stock. Finally, analysts at ISI Group raised their price target on shares of Illumina from $134.50 to $147.00 in a research note on Wednesday, January 29th. They now have a “neutral” rating on the stock. Six analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $117.24.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.